Hot off the heels of a US Food and Drug Administration (FDA) clearance for its surgical navigation platform in April, Proprio has secured $43m in a Series B financing round.
The round was conducted by existing and new investors and adds to previous venture financing and Series A rounds worth $7m and $23m respectively.
Proprio is backed by DCVC (Data Collective), BOLD Capital Partners, Cota Capital, Intel, HTC, and Alan Frazier, founder of Frazier Healthcare Partners. Bird B. AG, a global investment partnership, joined the investment group in the Series B round.
